Bio-Rad Laboratories Class BBIO.B
13F holders, Q3 2024 (September 30)6holders −2
1new positions
2sold out
$332.20avg. 13F price*
At the end of Q3 2024, 6 institutions reported holding Bio-Rad Laboratories Class B (BIO.B) in their 13F filings, down 2 from Q2 2024. 1 opened new positions and 2 sold out. The largest holders were CSS LLC ($499K), Focus Partners Wealth ($251K) and Morgan Stanley ($235K).
- Company
- Bio-Rad Laboratories Class B
- CUSIP
- 090572108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $251K |
| Exits | 2 | $875 |
All 13F filers, Q2 2024 → Q3 2024: 765 shares bought and 118 shares sold, net +647 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| CSS LLC | 0.09% | Reduce -7.2% | 1,492 | $499K |
| Focus Partners Wealth | 0.00% | New | 760 | $251K |
| Morgan Stanley | 0.00% | No change | 712 | $235K |
| Wells Fargo & Company | 0.00% | No change | 170 | $56K |
| Whittier Trust Co. | 0.00% | No change | 160 | $54K |
| Jones Financial Companies LLLP | 0.00% | Add +15.2% | 38 | $13K |
"% of holder's portfolio" is BIO.B's weight in each manager's 13F, not the share of Bio-Rad Laboratories Class B the manager owns.